Latest Security News

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Haranga Resources has launched the second phase of a 3,000-metre Aircore drilling campaign at its Ibel South Gold Project in Senegal, following promising high-grade gold results from its maiden program. The new drilling aims to confirm and expand mineralised zones ahead of a deeper 2026 drilling campaign.

Sun Silver Limited’s latest re-assay results confirm near-surface antimony mineralisation at its Maverick Springs Project, reinforcing its potential as a critical minerals hub alongside silver and gold. This comes as JPMorgan’s landmark US$75 million investment in U.S. antimony projects signals growing strategic focus on domestic mineral security.

Warriedar Resources shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Capricorn Metals, clearing a key hurdle ahead of final court approval and delisting.

Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.

Finexia Financial Group has formally ended preliminary discussions with Salter Brothers regarding a potential reverse listing and is seeking immediate reinstatement of its ASX securities.

The GPT Group has reported robust occupancy and sales growth across its property portfolios for the September quarter 2025, prompting an upgrade to its full-year earnings guidance.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

G11 Resources has successfully passed all resolutions at its November 2025 Extraordinary General Meeting, including approvals for a related party acquisition and a securities consolidation.